
EDAP TMS S.A. EDAP
$ 4.38
-4.58%
Quarterly report 2024-Q4
added 02-21-2026
EDAP TMS S.A. Operating Income 2011-2026 | EDAP
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income EDAP TMS S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -20.5 M | -19.8 M | -4.26 M | -1.61 M | 269 K | 2.2 M | -1.32 M | -2.03 M | 392 K | 488 K | -1.74 M | -2.76 M | -2.03 M | -2.5 M |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.2 M | -20.5 M | -3.94 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | ||
|
Alphatec Holdings
ATEC
|
-82.1 M | $ 13.94 | -0.71 % | $ 2.09 B | ||
|
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
-19.7 M | $ 14.09 | -7.06 % | $ 381 M | ||
|
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | ||
|
AxoGen
AXGN
|
-7.85 M | $ 31.87 | 2.07 % | $ 1.47 B | ||
|
Cognyte Software Ltd.
CGNT
|
-5.13 M | $ 7.0 | 5.74 % | $ 503 M | ||
|
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | ||
|
Electromed
ELMD
|
9.66 M | $ 24.18 | 1.09 % | $ 204 M | ||
|
Aziyo Biologics
AZYO
|
-30.5 M | - | 1.37 % | $ 20.5 M | ||
|
Apyx Medical Corporation
APYX
|
-17.3 M | $ 3.49 | 2.05 % | $ 121 M | ||
|
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | ||
|
Bio-Rad Laboratories
BIO
|
269 M | $ 275.33 | 2.19 % | $ 7.77 B | ||
|
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | ||
|
Bruker Corporation
BRKR
|
253 M | $ 40.88 | 2.48 % | $ 6.09 K | ||
|
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
3.61 B | $ 75.65 | 2.97 % | $ 112 B | ||
|
InMode Ltd.
INMD
|
85.4 M | $ 14.0 | 0.29 % | $ 905 M | ||
|
IRIDEX Corporation
IRIX
|
-10 M | $ 1.47 | -2.0 % | $ 23.7 M | ||
|
IRadimed Corporation
IRMD
|
22 M | $ 102.4 | 1.89 % | $ 1.3 B | ||
|
CONMED Corporation
CNMD
|
103 M | $ 45.89 | -0.18 % | $ 1.42 B | ||
|
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | ||
|
LivaNova PLC
LIVN
|
199 M | $ 71.26 | 1.38 % | $ 3.89 B | ||
|
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M | ||
|
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | ||
|
Medtronic PLC
MDT
|
5.96 B | $ 97.22 | 0.58 % | $ 125 B | ||
|
Delcath Systems
DCTH
|
-12.4 M | $ 9.11 | -10.77 % | $ 260 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
-56.7 M | $ 2.48 | 1.02 % | $ 146 M | ||
|
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | ||
|
Second Sight Medical Products
EYES
|
-24.7 M | - | -0.97 % | $ 54.4 M | ||
|
Establishment Labs Holdings
ESTA
|
-50 M | $ 77.41 | -1.12 % | $ 2.18 B | ||
|
Insulet Corporation
PODD
|
474 M | $ 251.74 | 1.46 % | $ 17.7 B | ||
|
Quanterix Corporation
QTRX
|
-49.7 M | $ 6.7 | 6.52 % | $ 252 M | ||
|
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | ||
|
FONAR Corporation
FONR
|
5.31 M | $ 18.53 | -0.3 % | $ 121 M | ||
|
Sintx Technologies
SINT
|
-13.4 M | $ 2.89 | -1.87 % | $ 10.8 M | ||
|
MiMedx Group
MDXG
|
63.9 M | $ 4.97 | -5.78 % | $ 735 M |